Physician profile
Daniel Davies
NPI 1316471220
$8,638.55
in general payments reported to CMS, 2019-2025
9 companies · $8,296 in 2025
The $8,296 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.10 · 2024: $312 · 2025: $8,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,670 · Food and Beverage: $1,878 · Travel and Lodging: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,670.00 |
| Food and Beverage | $1,877.75 |
| Travel and Lodging | $1,090.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $7,251.97 | 2024-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $452.56 | 2024-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $373.95 | 2024-2025 | Wainua |
| Bridgebio Pharma, INC. | $252.01 | 2025 | Attruby |
| Pfizer INC. | $127.88 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.70 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $40.09 | 2025 | |
| Zoll Circulation INC | $31.10 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Lantheus Medical Imaging, INC. | $29.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.